Ten63’s deal with Boehringer; Coya sets up agreement with Dr. Reddy’s; ReNAgade’s layoffs

Ten63 Therapeutics’ drug discovery deal with Boehringer Ingelheim: The Durham, NC-based startup, which is using generative AI to develop small molecule medicines, said the agreement spans multiple targets and disease areas. Financial details weren’t disclosed. Ten63 in May announced a $15.9 million Series A and plans to…
Click here to view original post